Advertisement

What’s New

Latest News

News
IBS Prevalence Slightly Above 6% in Pandemic-Era US Survey
03/28/2024

Jolynn Tumolo

Jolynn Tumolo
Almost half of those surveyed had not sought medical care for their IBS symptoms during the previous year.
Almost half of those surveyed had not sought medical care for their IBS symptoms during the previous year.
Almost half of those surveyed...
03/28/2024
Gastroenterology
Gastroenterology
This is a test
News
This is a test
03/21/2024
Amanda Balbi, Associate Director
This is a testThis is a testThis is a testThis is a testThis is a testThis is a testThis is a testThis is a testThis is a testThis is a testThis is a testThis is a testThis is a test
This is a testThis is a testThis is a testThis is a testThis is a testThis is a testThis is a testThis is a testThis is a testThis is a testThis is a testThis is a testThis is a test
This is a testThis is a testThis...
03/21/2024
Psych Congress NP Institute
Psych Congress NP Institute
News
ChatGPT Vs Multidisciplinary Tumor Board: Treatment Recommendations for Patients With Gynecologic Cancers
03/19/2024

Grace Taylor

Grace Taylor
Eric Rios-Doria, MD, and colleagues compared treatment recommendations for patients with gynecologic cancers made by ChatGPT vs a multidisciplinary tumor board.
Eric Rios-Doria, MD, and colleagues compared treatment recommendations for patients with gynecologic cancers made by ChatGPT vs a multidisciplinary tumor board.
Eric Rios-Doria, MD, and...
03/19/2024
Journal of Clinical Pathways
Journal of Clinical Pathways
Biomarkers
Potential Novel Biomarkers of Coronary Heart Disease Discovered
03/19/2024

Deutsches Zentrum fuer Diabetesforschung DZD News

Deutsches Zentrum fuer Diabetesforsch...
Among middle-aged adults, individuals with type 2 diabetes (T2D) have a two to four times higher risk of developing coronary heart disease than people without T2D. The research team investigated the predictive performance of protein...
Among middle-aged adults, individuals with type 2 diabetes (T2D) have a two to four times higher risk of developing coronary heart disease than people without T2D. The research team investigated the predictive performance of protein...
Among middle-aged adults,...
03/19/2024
Cath Lab Digest
Cath Lab Digest
News
Low COVID-19 and RSV Vaccination Rates in Nursing Homes
03/19/2024
Lisa Kuhns, PhD
In the ongoing battle against infectious diseases, nursing homes nationwide face a critical challenge: alarmingly low vaccination rates among residents and staff. In a webinar held by the Association of Health Care Journalists (AHCJ) on March...
In the ongoing battle against infectious diseases, nursing homes nationwide face a critical challenge: alarmingly low vaccination rates among residents and staff. In a webinar held by the Association of Health Care Journalists (AHCJ) on March...
In the ongoing battle against...
03/19/2024
Integrated Healthcare Executive
Integrated Healthcare Executive
News
VA Surgery Initiative Recognized for Eisenberg Patient Safety and Quality Award
03/19/2024
Lisa Kuhns, PhD
Veterans Affairs (VA) Surgical Pause Initiative has been recognized with the 2023 John M. Eisenberg Patient Safety and Quality Award, according to a press release from the VA.
Veterans Affairs (VA) Surgical Pause Initiative has been recognized with the 2023 John M. Eisenberg Patient Safety and Quality Award, according to a press release from the VA.
Veterans Affairs (VA) Surgical...
03/19/2024
Veterans Health Today
Veterans Health Today
News
Guidance Aims to Protect PD Patients from Harm During Hospitalization
03/19/2024
Jolynn Tumolo
Recommendations to improve the hospitalization experience of patients with Parkinson disease (PD), released last year by the Parkinson’s Foundation, aim to ease the increased risk of preventable harm for the hundreds of thousands of people...
Recommendations to improve the hospitalization experience of patients with Parkinson disease (PD), released last year by the Parkinson’s Foundation, aim to ease the increased risk of preventable harm for the hundreds of thousands of people...
Recommendations to improve the...
03/19/2024
Annals of Long-Term Care
Annals of Long-Term Care

Latest Research

First Report Managed Care
Navigating Work With PBMs: Negotiations, Misalignments, and Drug Costs
Vol. 20, Issue 4, Issue August 2024
CLD Nov 2023 cover
Cath Lab Digest
Staff Retention in a Time of Never-Ending National Shortages
Vol. 31, Issue 11, Issue August 2024
PT November 2023
Podiatry Today
Early Podiatric Interventions for Patients With Alcohol Use Disorder
Vol. 36, Issue 11, Issue August 2024

HMP Global Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Featured Interviews

Jack Jennings, MD, PhD, Washington University in St Louis
Videos
Treatment of Primary and Metastatic Sarcoma
02/06/2024

Featuring Jack Jennings, MD, PhD

Featuring Jack Jennings, MD, PhD ...
At the 2024 SIO Annual Meeting, Jack Jennings, MD, PhD, discussed the role of the interventional oncologist when treating primary or metastatic sarcomas of the bone or soft tissue.
At the 2024 SIO Annual Meeting, Jack Jennings, MD, PhD, discussed the role of the interventional oncologist when treating primary or metastatic sarcomas of the bone or soft tissue.
At the 2024 SIO Annual Meeting,...
02/06/2024
IO Learning
Saby George, MD
Conference Coverage
Subcutaneous Nivolumab Noninferior to Intravenous Administration Among Patients With Clear Cell Renal Cell Carcinoma
01/27/2024

Featuring Saby George, MD 

Featuring Saby George, MD 
Saby George shares insights from the CheckMate 67T evaluating the subcutaneous administration of nivolumab for patients with clear cell renal cell carcinoma, compared with the intravenous administration.
Saby George shares insights from the CheckMate 67T evaluating the subcutaneous administration of nivolumab for patients with clear cell renal cell carcinoma, compared with the intravenous administration.
Saby George shares insights from...
01/27/2024
Oncology
Michiel van der Heijden, MD 
Conference Coverage
Enfortumab Vedotin Plus Pembrolizumab Potential New Standard of Care for Advanced Urothelial Carcinoma in the First-Line Setting
01/26/2024

Featuring Michiel van der Heijden, MD 

Featuring Michiel van der Heijden, MD...
Michiel van der Heijden, MD, discusses the subgroup analyses of the phase 3 EV-302 study, evaluating enfortumab vedotin plus pembrolizumab among patients with locally advanced or metastatic urothelial carcinoma in the first-line setting.
Michiel van der Heijden, MD, discusses the subgroup analyses of the phase 3 EV-302 study, evaluating enfortumab vedotin plus pembrolizumab among patients with locally advanced or metastatic urothelial carcinoma in the first-line setting.
Michiel van der Heijden, MD,...
01/26/2024
Oncology
Thierry André, MD, Saint Antoine Hospital
Videos
Nivolumab Plus Ipilimumab Yields Superior PFS vs Chemotherapy for First-Line Treatment of Metastatic Colorectal Cancer
01/23/2024

Featuring Thierry André, MD

Featuring Thierry André, MD
Thierry Andre, MD, discusses the first results from the CheckMate 8HW study exploring nivolumab plus chemotherapy for the first-line treatment of microsatellite instability-high, mismatch repair-deficient metastatic colorectal cancer.
Thierry Andre, MD, discusses the first results from the CheckMate 8HW study exploring nivolumab plus chemotherapy for the first-line treatment of microsatellite instability-high, mismatch repair-deficient metastatic colorectal cancer.
Thierry Andre, MD, discusses the...
01/23/2024
Oncology
Riccardo Lencioni, MD, University of Pisa School of Medicine
Videos
Addition of Durvalumab, Bevacizumab to TACE for Hepatocellular Carcinoma Improves PFS
01/23/2024

Featuring Riccardo Lencioni, MD

Featuring Riccardo Lencioni, MD ...
Ricardo Lencioni, MD, shares results from the phase 3 EMERALD-1 study which found the addition of durvalumab and bevacizumab to TACE improved progression-free survival among patients with hepatocellular carcinoma, compared with TACE alone.
Ricardo Lencioni, MD, shares results from the phase 3 EMERALD-1 study which found the addition of durvalumab and bevacizumab to TACE improved progression-free survival among patients with hepatocellular carcinoma, compared with TACE alone.
Ricardo Lencioni, MD, shares...
01/23/2024
Oncology
Anant Ramaswamy, MD, Tata Memorial Hospital
Videos
Addition of Docetaxel to FOLFOX/CAPOX Backbone Fails to Improve OS in Advanced GEJ/Gastric Cancer
01/20/2024

Featuring Anant Ramaswamy, MD

Featuring Anant Ramaswamy, MD
Anant Ramaswamy, MD, discusses results from the phase 3 DOC-GC study which explored the efficacy of docetaxel added to a FOLFOX/CAPOX backbone for patients with advanced GEJ and gastric cancers.
Anant Ramaswamy, MD, discusses results from the phase 3 DOC-GC study which explored the efficacy of docetaxel added to a FOLFOX/CAPOX backbone for patients with advanced GEJ and gastric cancers.
Anant Ramaswamy, MD, discusses...
01/20/2024
Oncology
Yelena Janjigian, MD, Memorial Sloan Kettering Cancer Center
Videos
Global Treatment of Gastric/GEJ Cancer with Durvalumab Plus FLOT
01/19/2024

Featuring Yelena Janjigian, MD

Featuring Yelena Janjigian, MD ...
Yelena Janjigian, MD, discussed the recent subgroup analysis from the MATTERHORN study, evaluating durvalumab plus FLOT for patients with gastric or gastroesophageal junction cancer.
Yelena Janjigian, MD, discussed the recent subgroup analysis from the MATTERHORN study, evaluating durvalumab plus FLOT for patients with gastric or gastroesophageal junction cancer.
Yelena Janjigian, MD, discussed...
01/19/2024
Oncology
Live From Expo 2023: Peter Antevy and Charlie Coyle on the Wall Time Problem
Podcasts
Live From Expo 2023: Peter Antevy and Charlie Coyle on the Wall Time Problem
10/27/2023

Guests: Charlie Coyle and Dr. Peter Antevy

Guests: Charlie Coyle and Dr. Peter A...
In this episode direct from the exhibit hall floor, Mike McCabe sits down with two esteemed friends—Chief Charlie Coyle and Dr. Peter Antevy from Florida—for a hard-hitting discussion on "wall time" in EMS.
In this episode direct from the exhibit hall floor, Mike McCabe sits down with two esteemed friends—Chief Charlie Coyle and Dr. Peter Antevy from Florida—for a hard-hitting discussion on "wall time" in EMS.
In this episode direct from the...
10/27/2023
EMSWorld
Windy Cole, DPM
Podcasts
Pain and the Journey of the Chronic Wound Patient
10/27/2023

Featuring Windy Cole, DPM, CWSP, FACCWS

Featuring Windy Cole, DPM, CWSP, FACC...
Dr. Cole delves into pain management and its role in the chronic wound patient's journey. She also addresses a novel option from her experience and in the literature.
Dr. Cole delves into pain management and its role in the chronic wound patient's journey. She also addresses a novel option from her experience and in the literature.
Dr. Cole delves into pain...
10/27/2023
Podiatry Today
Dr. Nair and Schloss
Podcasts
Innovation and Passion in Electrophysiology: Interview With Devi Nair, MD
10/23/2023

Podcast discussion edited by Jodie Elrod

Podcast discussion edited by Jodie El...
In this episode of The EP Edit podcast, we feature a discussion between Devi Nair, MD, and Edward J Schloss, MD. Dr Schloss talks with Dr Nair about her long and successful career in cardiac electrophysiology (EP).
In this episode of The EP Edit podcast, we feature a discussion between Devi Nair, MD, and Edward J Schloss, MD. Dr Schloss talks with Dr Nair about her long and successful career in cardiac electrophysiology (EP).
In this episode of The EP Edit...
10/23/2023
EP Lab Digest

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use